Elixinol Wellness Limited (EXL.AX) Stock Analysis & Winston Score
Elixinol Wellness Limited is an Australian company that makes and sells hemp-derived CBD (cannabidiol) products. Its main products include CBD oils, capsules, and wellness supplements sold to everyday consumers who want natural health and wellness options. The company operates in the specialty health products space and sells under the Elixinol brand, which has been one of the more recognized names in the hemp CBD market. Elixinol makes money by selling its products directly to consumers online and through retail partners, primarily in Australia, the United States, and Europe. The company is small, with a market cap near zero, and it has struggled to turn a profit — its operating margin was deeply negative in recent periods, meaning it spends far more than it earns. The biggest risk the business faces is ongoing regulatory uncertainty around CBD products in key markets, combined with intense competition and the challenge of scaling revenue fast enough to cover its costs.
Winston Score: 23/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (9/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)

